Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial

被引：0
|
作者：
Soufila KT
Vishal Thakur
Tarun Narang
Sunil Dogra
Sanjeev Handa
机构：
[1] Postgraduate Institute of Medical Education and Research,Department of Dermatology, Venereology and Leprology
来源：
American Journal of Clinical Dermatology | 2021年 / 22卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：415 / 423
页数：8
相关论文
共 50 条
  • [41] Efficacy and safety of apremilast in patients with limited skin involvement, plaque psoriasis in special areas and impaired quality of life: Results from the EMBRACE randomized trial
    Mrowietz, Ulrich
    Barker, Jonathan
    Conrad, Curdin
    Jullien, Denis
    Gisondi, Paolo
    Flower, Andrea
    Reddy, Jyotsna
    Paris, Maria
    Picard, Hernan
    Jardon, Shauna
    Augustin, Matthias
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2023, 37 (02) : 348 - 355
  • [42] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Song, Gwan Gyu
    Lee, Young Ho
    CLINICAL DRUG INVESTIGATION, 2019, 39 (05) : 421 - 428
  • [43] Efficacy, safety and usability of secukinumab administration by autoinjector/pen in psoriasis: a randomized, controlled trial (JUNCTURE)
    Paul, C.
    Lacour, J. -P.
    Tedremets, L.
    Kreutzer, K.
    Jazayeri, S.
    Adams, S.
    Guindon, C.
    You, R.
    Papavassilis, C.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (06) : 1082 - 1090
  • [44] Safety and efficacy of silymarin on patients with acute hepatitis: A randomized, controlled trial
    El-Kamary, Samer
    Shardell, Michelle
    Metwally, Mohamed
    Esmat, Gamal
    Mikhal, Nabiel
    Hashem, Mohamed
    Abdelhamid, Mohamed
    Strickland, G. Thomas
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (05): : 210 - 210
  • [45] COMPARISON OF THE EFFICACY AND SAFETY OF TOFACITINIB AND APREMILAST IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: A BAYESIAN NETWORK META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
    Lee, Young Ho
    Song, Gwan Gyu
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1275 - 1276
  • [46] Comparison of the Efficacy and Safety of Tofacitinib and Apremilast in Patients with Active Psoriatic Arthritis: A Bayesian Network Meta-Analysis of Randomized Controlled Trials
    Gwan Gyu Song
    Young Ho Lee
    Clinical Drug Investigation, 2019, 39 : 421 - 428
  • [47] Efficacy and safety of Rhus coriaria in patients with hyperlipidemia: A randomized controlled trial
    Hajmohammadi, Z.
    Shams, M.
    Zibainejad, M. Javad
    Nimrouzi, M.
    Fardidi, P.
    Heydari, M.
    PLANTA MEDICA, 2016, 82
  • [48] The efficacy of methotrexate plus pioglitazone vs. methotrexate alone in the management of patients with plaque-type psoriasis: a single-blinded randomized controlled trial
    Lajevardi, Vahide
    Hallaji, Zahra
    Daklan, Soroush
    Abedini, Robabeh
    Goodarzi, Azadeh
    Abdolreza, Mona
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2015, 54 (01) : 95 - 101
  • [49] Apremilast, an oral phosphodiesterase-4 inhibitor, in the treatment of palmoplantar psoriasis: Results of a pooled analysis from phase II PSOR-005 and phase III Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis (ESTEEM) clinical trials in patients with moderate to severe psoriasis
    Bissonnette, Robert
    Pariser, David M.
    Wasel, Norman R.
    Goncalves, Joana
    Day, Robert M.
    Chen, Rongdean
    Sebastian, Michael
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 75 (01) : 99 - 105
  • [50] A Comparative Study of the Efficacy of Methotrexate versus Methotrexate with Apremilast in Moderate to Severe Chronic Plaque Psoriasis
    Srivastava, Divyanshu
    Krishna, Arvind
    David, Abhinav
    INDIAN JOURNAL OF DERMATOLOGY, 2023, 68 (04) : 393 - 398
12345